Acceler8 Ventures plans £1m fundraise via convertible notes

Acceler8 Ventures (AC8) plans to raise ~£1.0m via unsecured 2026 convertible loan notes carrying 8% PIK interest compounded annually, auto-converting on completion of an initial transaction or at the third anniversary. If the proposed all-share transaction with Intuitive Investments Group proceeds, the 2026 notes will convert at 34p (a 57.5% discount to the prior mid-market price) and the August 2025 notes would be effectively adjusted to 28p (a 65% discount). A general meeting is scheduled for 27 April 2026 to approve the 2026 issuance and related amendments; the notes are unsecured, pari passu with other unsecured creditors and carry no standard redemption rights. If the deal completes, AC8 shareholders would hold ~0.99% of the enlarged group's issued ordinary share capital, indicating material dilution risk for existing holders.

Analysis

This transaction is best read as a liquidity-and-control story rather than a simple financing — the structure shifts future value capture from existing equity to new money and noteholders, effectively turning current shareholders into minority holders of whatever comes after the corporate action. The pay-in-kind compounding and conversion mechanics accelerate upstream supply of equity at the margin, creating a significant overhang risk for the free float that can depress secondary liquidity for months.

Second-order effects: brokers and small-cap specialist funds holding the stock will face margin and mark-to-market pressure as implied supply rises, which can force selling into any softness and amplify volatility; similarly, peer shell/microcap issuers will see risk premia widen for convertible financings, pushing them to pricier dilutive solutions or strategic auctions. There is also a non-trivial litigation and governance angle — minority shareholders and coordinated noteholders have real leverage to extract concessions or delay a deal, which creates event-driven windows for alpha.

Key catalysts and risks cluster around near-term governance events and counterparty moves: an imminent shareholder decision, potential competing offers, or coordinated creditor action can each flip the outcome within weeks; conversely, failure to secure approvals will likely compress runway and increase bankruptcy tail risk over months. Watch insider flows, borrow availability, and any secondary placements — they will telegraph whether the market expects a smooth deal or a rescue financing that further dilutes equity.

Key Decisions for Investors

• Short AC8.L equity (size 1–2% NAV) + buy a 3–6 month out-of-the-money call to cap tail risk — objective: harvest 30–100% downside from dilution-driven repricing while limiting blow-up from short squeezes. Trim into any >10% intraday rallies and tighten stop if borrow becomes scarce.
• Long IIG.L (or long IIG.L calls 3–6 months) as a deal-completion play — if the market underprices the merger arbitrage, this offers asymmetric upside should the target extract better economics or receive competing bids. Size 1–3% NAV, hedge with a small AC8.L short to neutralize market beta.
• If convertible notes or secondary debt trade in the market, selectively buy the unsecured paper (target IRR 15–30% annualized) while organizing bilateral engagement with other creditors — activism can materially improve recoveries or conversion economics. Only execute after confirming tradeable liquidity and legal ranking.
• Avoid providing incremental secured or unsecured credit to the issuer; instead, sell any high-cost existing exposure and redeploy into event-driven small-cap arbitrage where governance is cleaner. Prefer pair trades (long target / short acquirer-shell) to isolate deal risk and reduce outright market direction exposure.